Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study

INTRODUCTION: The present study was designed to evaluate the effect of granulocyte-colony stimulating factor (G-CSF) in the treatment of Parkinson's disease (PD), the second most common neurodegenerative disease characterized by muscle and movement disorder, often associated with depression. PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Ajay, Chopra, Kanwaljit, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847253/
https://www.ncbi.nlm.nih.gov/pubmed/24347771
http://dx.doi.org/10.4103/0253-7613.121374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847253/
https://www.ncbi.nlm.nih.gov/pubmed/24347771
http://dx.doi.org/10.4103/0253-7613.121374

Ejemplares similares